|
| 38070511 | Baloxavir marboxil use for critical human infection of avian influenza A H5N6 virus. | Med | 2024 |
| 36323380 | Significance and Potential Role of Eosinophils in Non-Cystic Fibrosis Bronchiectasis. | J Allergy Clin Immunol Pract | 2023 |
| 37919749 | Differential airway resistome and its correlations with clinical characteristics in Haemophilus- or Pseudomonas-predominant microbial subtypes of bronchiectasis. | Respir Res | 2023 |
| 38017515 | Effects of Lianhuaqingwen Capsules in adults with mild-to-moderate coronavirus disease 2019: an international, multicenter, double-blind, randomized controlled trial. | Virol J | 2023 |
| 37161410 | Advances in pharmacotherapy for bronchiectasis in adults. | Expert Opin Pharmacother | 2023 |
| 36949966 | Airway clearance technique in the modern era of bronchiectasis management. | ERJ Open Res | 2023 |
| 37349537 | The airway microbiome mediates the interaction between environmental exposure and respiratory health in humans. | Nat Med | 2023 |
| 37386364 | Effect of hydrogen/oxygen therapy for ordinary COVID-19 patients: a propensity-score matched case-control study. | BMC Infect Dis | 2023 |
| 37143843 | The BED-Pro Tool: facilitating the detection of bronchiectasis exacerbations. | ERJ Open Res | 2023 |
| 37377656 | Endobronchial optical coherence tomography or computed tomography for evaluating progression of bronchiectasis. | ERJ Open Res | 2023 |
| 37038356 | Sputum pathogen spectrum and clinical outcomes of upper respiratory tract infection in bronchiectasis exacerbation: a prospective cohort study. | Emerg Microbes Infect | 2023 |
| 37005365 | Real-World Effectiveness of Primary Series and Booster Doses of Inactivated Coronavirus Disease 2019 Vaccine Against Omicron BA.2 Variant Infection in China: A Retrospective Cohort Study. | J Infect Dis | 2023 |
| 37065584 | Real-time assessment of COVID-19 epidemic in Guangdong Province, China using mathematical models. | J Thorac Dis | 2023 |
| 36855043 | Post-TB bronchiectasis: from pathogenesis to rehabilitation. | Int J Tuberc Lung Dis | 2023 |
| 36435264 | Motile Ciliary Disorders of the Nasal Epithelium in Adults With Bronchiectasis. | Chest | 2023 |
| 36707228 | The transcriptomic landscape of diffuse radiological bronchiectasis. | Eur Respir J | 2023 |
| 36731904 | Insights into the clinical outcomes of bronchiectasis. | Eur Respir J | 2023 |
| 35863486 | A Double-Blind Randomized Placebo-Controlled Phase 3 Trial of Tobramycin Inhalation Solution in Adults With Bronchiectasis With Pseudomonas aeruginosa Infection. | Chest | 2023 |
| 34242153 | Genetic Risk and Chronic Obstructive Pulmonary Disease Independently Predict the Risk of Incident Severe COVID-19. | Ann Am Thorac Soc | 2022 |
| 35401988 | Strategies for reopening in the forthcoming COVID-19 era in China. | Natl Sci Rev | 2022 |
| 35399246 | Chinese expert consensus on immunoprophylaxis of common respiratory pathogens in children (2021 edition). | J Thorac Dis | 2022 |
| 35431398 | The Short- and Long-Term Clinical, Radiological and Functional Consequences of COVID-19. | Arch Bronconeumol | 2022 |
| 35789796 | Anti-Interferon-γ Autoantibodies Impair T-Lymphocyte Responses in Patients with <i>Talaromyces marneffei</i> Infections. | Infect Drug Resist | 2022 |
| 35788298 | Advances in Bronchiectasis Registries: The New Chinese Registry. | Arch Bronconeumol | 2022 |
| 35415184 | Research advances and clinical management of bronchiectasis: Chinese perspective. | ERJ Open Res | 2022 |
| 36463140 | The Establishment of China Bronchiectasis Registry and Research Collaboration (BE-China): Protocol of a prospective multicenter observational study. | Respir Res | 2022 |
| 35896532 | SARS-CoV-2 nucleocapsid protein triggers hyperinflammation via protein-protein interaction-mediated intracellular Cl<sup>-</sup> accumulation in respiratory epithelium. | Signal Transduct Target Ther | 2022 |
| 35318858 | Angiotensin-converting enzyme 2 in peripheral lung club cells modulates the susceptibility to SARS-CoV-2 in chronic obstructive pulmonary disease. | Am J Physiol Lung Cell Mol Physiol | 2022 |
| 35154032 | Different Circulation Pattern of Multiple Respiratory Viruses in Southern China During the COVID-19 Pandemic. | Front Microbiol | 2022 |
| 35042537 | MUC5B regulates goblet cell differentiation and reduces inflammation in a murine COPD model. | Respir Res | 2022 |
| 35280492 | Co-infecting pathogens can contribute to inflammatory responses and severe symptoms in COVID-19. | J Thorac Dis | 2022 |
| 35071262 | Decreased Systemic and Airway Sirtuin 1 Expression in Adults With Bronchiectasis. | Front Med (Lausanne) | 2022 |
| 34988656 | Artificial intelligence for stepwise diagnosis and monitoring of COVID-19. | Eur Radiol | 2022 |
| 34437708 | Airway remodeling and bronchodilator responses in asthma assessed by endobronchial optical coherence tomography. | Allergy | 2022 |
| 34775361 | Efficacy and safety of Lianhua Qingwen capsules, a repurposed Chinese herb, in patients with Coronavirus disease 2019: A multicenter, prospective, randomized controlled trial [Phytomedicine 85 (2021) 153242]. | Phytomedicine | 2022 |
| 34796997 | Impact of polluting fuels for cooking on diabetes mellitus and glucose metabolism in south urban China. | Indoor Air | 2022 |
| 34075267 | Impact of Chronic Respiratory Diseases on the Outcomes of COVID-19. | Arch Bronconeumol | 2022 |
| 32910179 | Effect of Recombinant Human Granulocyte Colony-Stimulating Factor for Patients With Coronavirus Disease 2019 (COVID-19) and Lymphopenia: A Randomized Clinical Trial. | JAMA Intern Med | 2021 |
| 33684635 | Chronic Respiratory Diseases and the Outcomes of COVID-19: A Nationwide Retrospective Cohort Study of 39,420 Cases. | J Allergy Clin Immunol Pract | 2021 |
| 33601224 | Short-term exposure to ozone, nitrogen dioxide, and sulphur dioxide and emergency department visits and hospital admissions due to asthma: A systematic review and meta-analysis. | Environ Int | 2021 |
| 33569239 | Erratum to risk factors and predictors associated with the severity of COVID-19 in China: a systematic review, meta-analysis, and meta-regression. | J Thorac Dis | 2021 |
| 33511374 | Clinical characteristics of COVID-19 in developing countries of western pacific: Low case-fatality rate unraveled. | Lancet Reg Health West Pac | 2021 |
| 33867046 | Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial. | Phytomedicine | 2021 |
| 33812878 | Exposure to biomass fuel is associated with high blood pressure and fasting blood glucose impairment in females in southern rural China. | Environ Res | 2021 |
| 33526778 | Addendum: Early triage of critically ill COVID-19 patients using deep learning. | Nat Commun | 2021 |
| 34412743 | [A multicenter prospective cohort study of Xuebijing injection in the treatment of severe coronavirus disease 2019]. | Zhonghua Wei Zhong Bing Ji Jiu Yi Xue | 2021 |
| 34496522 | [<i>Chlamydia psittaci</i> pneumonia complicated with rhabdomyolysis: a case report and literature review]. | Zhonghua Jie He He Hu Xi Za Zhi | 2021 |
| 34670161 | Efficacy and Safety of Lianhuaqingwen Capsules, a repurposed Chinese Herb, in Patients with Coronavirus disease 2019: A multicenter, prospective, randomized controlled trial [Phytomedicine 85 (2021) 153242]. | Phytomedicine | 2021 |
| 34840136 | Aggressive containment, suppression, and mitigation of covid-19: lessons learnt from eight countries. | BMJ | 2021 |
| 34631744 | Exhaled Volatile Organic Compounds for Identifying Patients With Chronic Pulmonary Aspergillosis. | Front Med (Lausanne) | 2021 |